Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (421-430 of 464) with videos related to

Pageof 47
Sort By:
Alimentary Pharmacology & Therapeutics|January 7, 2021
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trialsAhmed Almradi, Christopher Ma, Geert R D'Haens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 12, 2023
Standardizing Scoring Conventions for Crohn's Disease Endoscopy: An International RAND/UCLA Appropriateness StudyReena Khanna, Christopher Ma, Malcolm Hogan, et al.
JAMA|April 10, 2008
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled TrialsBrian G Feagan, William J Sandborn, Ulrich Mittmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Reliability of Intestinal Ultrasound for Evaluating Crohn's Disease Activity Using Point-of-care and Central ReadingThomas M Goodsall, Yoon-Kyo An, Jane M Andrews, et al.
Digestive Diseases and Sciences|November 27, 2022
An Expert Consensus to Standardize Assessment of Bowel Cleansing for Clinical Trials of Bowel Preparations for Crohn's DiseaseJennifer K Maratt, Corey A Siegel, Alan N Barkun, et al.
The Cochrane Database of Systematic Reviews|September 9, 2017
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitisVipul Jairath, G Y Zou, Claire E Parker, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2018
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension studyBrian G Feagan, Julián Panés, Marc Ferrante, et al.
Alimentary Pharmacology & Therapeutics|March 4, 2024
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasoundCathy Lu, Ryan Rosentreter, Maxime Delisle, et al.
Gastroenterology|November 3, 2015
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative ColitisGaik W Tew, Jason A Hackney, Deena Gibbons, et al.
Lancet (London, England)|May 13, 2014
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trialSéverine Vermeire, Sharon O'Byrne, Mary Keir, et al.
Pageof 47

Showing results (421-430 of 464) with videos related to

Sort By:
Pageof 47
Alimentary Pharmacology & Therapeutics|January 7, 2021
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trialsAhmed Almradi, Christopher Ma, Geert R D'Haens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 12, 2023
Standardizing Scoring Conventions for Crohn's Disease Endoscopy: An International RAND/UCLA Appropriateness StudyReena Khanna, Christopher Ma, Malcolm Hogan, et al.
JAMA|April 10, 2008
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled TrialsBrian G Feagan, William J Sandborn, Ulrich Mittmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Reliability of Intestinal Ultrasound for Evaluating Crohn's Disease Activity Using Point-of-care and Central ReadingThomas M Goodsall, Yoon-Kyo An, Jane M Andrews, et al.
Digestive Diseases and Sciences|November 27, 2022
An Expert Consensus to Standardize Assessment of Bowel Cleansing for Clinical Trials of Bowel Preparations for Crohn's DiseaseJennifer K Maratt, Corey A Siegel, Alan N Barkun, et al.
The Cochrane Database of Systematic Reviews|September 9, 2017
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitisVipul Jairath, G Y Zou, Claire E Parker, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2018
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension studyBrian G Feagan, Julián Panés, Marc Ferrante, et al.
Alimentary Pharmacology & Therapeutics|March 4, 2024
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasoundCathy Lu, Ryan Rosentreter, Maxime Delisle, et al.
Gastroenterology|November 3, 2015
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative ColitisGaik W Tew, Jason A Hackney, Deena Gibbons, et al.
Lancet (London, England)|May 13, 2014
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trialSéverine Vermeire, Sharon O'Byrne, Mary Keir, et al.
Pageof 47